These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system. Hjerrild KA; Jin J; Wright KE; Brown RE; Marshall JM; Labbé GM; Silk SE; Cherry CJ; Clemmensen SB; Jørgensen T; Illingworth JJ; Alanine DG; Milne KH; Ashfield R; de Jongh WA; Douglas AD; Higgins MK; Draper SJ Sci Rep; 2016 Jul; 6():30357. PubMed ID: 27457156 [TBL] [Abstract][Full Text] [Related]
3. Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination. Minassian AM; Silk SE; Barrett JR; Nielsen CM; Miura K; Diouf A; Loos C; Fallon JK; Michell AR; White MT; Edwards NJ; Poulton ID; Mitton CH; Payne RO; Marks M; Maxwell-Scott H; Querol-Rubiera A; Bisnauthsing K; Batra R; Ogrina T; Brendish NJ; Themistocleous Y; Rawlinson TA; Ellis KJ; Quinkert D; Baker M; Lopez Ramon R; Ramos Lopez F; Barfod L; Folegatti PM; Silman D; Datoo M; Taylor IJ; Jin J; Pulido D; Douglas AD; de Jongh WA; Smith R; Berrie E; Noe AR; Diggs CL; Soisson LA; Ashfield R; Faust SN; Goodman AL; Lawrie AM; Nugent FL; Alter G; Long CA; Draper SJ Med; 2021 Jun; 2(6):701-719.e19. PubMed ID: 34223402 [TBL] [Abstract][Full Text] [Related]
4. Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal 'C-tag'. Jin J; Hjerrild KA; Silk SE; Brown RE; Labbé GM; Marshall JM; Wright KE; Bezemer S; Clemmensen SB; Biswas S; Li Y; El-Turabi A; Douglas AD; Hermans P; Detmers FJ; de Jongh WA; Higgins MK; Ashfield R; Draper SJ Int J Parasitol; 2017 Jun; 47(7):435-446. PubMed ID: 28153778 [TBL] [Abstract][Full Text] [Related]
5. A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein. Ord RL; Caldeira JC; Rodriguez M; Noe A; Chackerian B; Peabody DS; Gutierrez G; Lobo CA Malar J; 2014 Aug; 13():326. PubMed ID: 25135070 [TBL] [Abstract][Full Text] [Related]
7. One-step design of a stable variant of the malaria invasion protein RH5 for use as a vaccine immunogen. Campeotto I; Goldenzweig A; Davey J; Barfod L; Marshall JM; Silk SE; Wright KE; Draper SJ; Higgins MK; Fleishman SJ Proc Natl Acad Sci U S A; 2017 Jan; 114(5):998-1002. PubMed ID: 28096331 [TBL] [Abstract][Full Text] [Related]
8. Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions. Payne RO; Silk SE; Elias SC; Miura K; Diouf A; Galaway F; de Graaf H; Brendish NJ; Poulton ID; Griffiths OJ; Edwards NJ; Jin J; Labbé GM; Alanine DG; Siani L; Di Marco S; Roberts R; Green N; Berrie E; Ishizuka AS; Nielsen CM; Bardelli M; Partey FD; Ofori MF; Barfod L; Wambua J; Murungi LM; Osier FH; Biswas S; McCarthy JS; Minassian AM; Ashfield R; Viebig NK; Nugent FL; Douglas AD; Vekemans J; Wright GJ; Faust SN; Hill AV; Long CA; Lawrie AM; Draper SJ JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093263 [TBL] [Abstract][Full Text] [Related]
9. Functional Comparison of Blood-Stage Illingworth JJ; Alanine DG; Brown R; Marshall JM; Bartlett HE; Silk SE; Labbé GM; Quinkert D; Cho JS; Wendler JP; Pattinson DJ; Barfod L; Douglas AD; Shea MW; Wright KE; de Cassan SC; Higgins MK; Draper SJ Front Immunol; 2019; 10():1254. PubMed ID: 31214195 [TBL] [Abstract][Full Text] [Related]
10. Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5. Wang LT; Cooper AJR; Farrell B; Miura K; Diouf A; Müller-Sienerth N; Crosnier C; Purser L; Kirtley PJ; Maciuszek M; Barrett JR; McHugh K; Ogwang R; Tucker C; Li S; Doumbo S; Doumtabe D; Pyo CW; Skinner J; Nielsen CM; Silk SE; Kayentao K; Ongoiba A; Zhao M; Nguyen DC; Lee FE; Minassian AM; Geraghty DE; Traore B; Seder RA; Wilder BK; Crompton PD; Wright GJ; Long CA; Draper SJ; Higgins MK; Tan J Cell; 2024 Jul; ():. PubMed ID: 39059381 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype. Barrett JR; Pipini D; Wright ND; Cooper AJR; Gorini G; Quinkert D; Lias AM; Davies H; Rigby CA; Aleshnick M; Williams BG; Bradshaw WJ; Paterson NG; Martinson T; Kirtley P; Picard L; Wiggins CD; Donnellan FR; King LDW; Wang LT; Popplewell JF; Silk SE; de Ruiter Swain J; Skinner K; Kotraiah V; Noe AR; MacGill RS; King CR; Birkett AJ; Soisson LA; Minassian AM; Lauffenburger DA; Miura K; Long CA; Wilder BK; Koekemoer L; Tan J; Nielsen CM; McHugh K; Draper SJ Cell; 2024 Jul; ():. PubMed ID: 39059380 [TBL] [Abstract][Full Text] [Related]
12. Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria. Tran TM; Ongoiba A; Coursen J; Crosnier C; Diouf A; Huang CY; Li S; Doumbo S; Doumtabe D; Kone Y; Bathily A; Dia S; Niangaly M; Dara C; Sangala J; Miller LH; Doumbo OK; Kayentao K; Long CA; Miura K; Wright GJ; Traore B; Crompton PD J Infect Dis; 2014 Mar; 209(5):789-98. PubMed ID: 24133188 [TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in malaria vaccine candidate Plasmodium falciparum reticulocyte-binding protein homologue-5 among populations in Lagos, Nigeria. Ajibaye O; Osuntoki AA; Balogun EO; Olukosi YA; Iwalokun BA; Oyebola KM; Hikosaka K; Watanabe YI; Ebiloma GU; Kita K; Amambua-Ngwa A Malar J; 2020 Jan; 19(1):6. PubMed ID: 31906953 [TBL] [Abstract][Full Text] [Related]
14. APC-Targeted DNA Vaccination Against Reticulocyte-Binding Protein Homolog 5 Induces Bjerkan L; Visweswaran GRR; Gudjonsson A; Labbé GM; Quinkert D; Pattinson DJ; Spång HCL; Draper SJ; Bogen B; Braathen R Front Immunol; 2021; 12():720550. PubMed ID: 34733274 [TBL] [Abstract][Full Text] [Related]
15. Development of a process for large scale production of PfRH5 in E. coli expression system. Raghuwanshi AS; Kumar A; Raghuwanshi N; Singh SK; Singh AK; Tripathi U; Kaviraj S; Singh S Int J Biol Macromol; 2021 Oct; 188():169-179. PubMed ID: 34364940 [TBL] [Abstract][Full Text] [Related]
16. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate. Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771 [TBL] [Abstract][Full Text] [Related]
17. Extent and Dynamics of Polymorphism in the Malaria Vaccine Candidate Ouattara A; Tran TM; Doumbo S; Adams M; Agrawal S; Niangaly A; Nelson-Owens S; Doumtabé D; Tolo Y; Ongoiba A; Takala-Harrison S; Traoré B; Silva JC; Crompton PD; Doumbo OK; Plowe CV Am J Trop Med Hyg; 2018 Jul; 99(1):43-50. PubMed ID: 29848401 [TBL] [Abstract][Full Text] [Related]
18. Association of antibodies to Plasmodium falciparum reticulocyte binding protein homolog 5 with protection from clinical malaria. Chiu CY; Healer J; Thompson JK; Chen L; Kaul A; Savergave L; Raghuwanshi A; Li Wai Suen CS; Siba PM; Schofield L; Mueller I; Cowman AF; Hansen DS Front Microbiol; 2014; 5():314. PubMed ID: 25071730 [TBL] [Abstract][Full Text] [Related]
19. Identification and Immune Assessment of T Cell Epitopes in Five Kotraiah V; Phares TW; Terry FE; Hindocha P; Silk SE; Nielsen CM; Moise L; Tucker KD; Ashfield R; Martin WD; De Groot AS; Draper SJ; Gutierrez GM; Noe AR Front Immunol; 2021; 12():690348. PubMed ID: 34305923 [TBL] [Abstract][Full Text] [Related]
20. Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge. Wang SH; Smith D; Cao Z; Chen J; Acosta H; Chichester JA; Yusibov V; Streatfield SJ; Fattom A; Baker JR Vaccine; 2019 Mar; 37(12):1591-1600. PubMed ID: 30795941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]